Skip to main content
Sirona Biochem Corp. logo

Sirona Biochem Corp. — Investor Relations & Filings

Ticker · SRBCF ISIN · CA82967M1005 LEI · 549300CQE1Q87IG6W210 TSXV Real estate activities
Filings indexed 367 across all filing types
Latest filing 2020-06-16 Regulatory Filings
Country CA Canada
Listing TSXV SRBCF

About Sirona Biochem Corp.

https://www.sironabiochem.com/

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery firm utilizing a proprietary platform technology to develop novel compounds. Through its wholly-owned French subsidiary, TFChem, the company specializes in stabilizing carbohydrate molecules, often via fluorination chemistry, to enhance their efficacy and safety for medical and cosmetic applications. Sirona Biochem's business strategy involves licensing or selling its patented compounds, such as the anti-aging and anti-wrinkle molecule GlycoProteMim™ (TFC-1326), to leading global pharmaceutical and cosmetic companies in exchange for up-front fees, milestone payments, and ongoing royalties.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the shipment of a compound (TFC-1067) by Sirona Biochem to Rodan + Fields. It discusses product development, manufacturing scale-up, and strategic plans but does not contain financial statements, regulatory filings, or detailed financial data. There is no indication that this is an earnings release, annual or interim report, or any other formal financial or regulatory filing. It is a corporate announcement about a business development and product shipment, which does not fit into the specific categories for financial or regulatory reports. Therefore, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous corporate announcements that do not fit other categories.
2020-06-16 English
Other.PDF
Regulatory Filings
2020-05-29 English
News release - English.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement of the results of the Annual General Meeting (AGM) of Sirona Biochem Corp. It details the voting results on various resolutions including election of directors and approval of plans. The text explicitly states it is announcing the results of the AGM held on May 22, 2020. There is no detailed presentation or materials from the AGM, nor is it a full annual report or financial statement. The document is relatively short (3827 characters) and serves as a formal announcement of voting outcomes from the AGM. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2020-05-26 English
News release - English.pdf
Regulatory Filings
2020-05-19 English
News release - English.pdf
Regulatory Filings
2020-04-21 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing an interview with the Chief Scientific Officer of Sirona Biochem Corp. It discusses the company's development pipeline, scientific innovations, and upcoming projects. There is no presentation of financial data, regulatory filings, or formal report content such as annual or quarterly financial statements. The document is informational and promotional in nature, aimed at investors and the public, without any indication of being a formal financial or regulatory report. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is also not a presentation or call transcript but rather a news announcement. Therefore, the best fitting category is Regulatory Filings (RNS) as a general regulatory announcement and press release that does not fit other specific categories.
2020-04-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.